Medical/Pharmaceuticals

Biosyngen's BRG01 enters Phase II clinical trial, a first-in-kind autologous EBV-Specific CAR-T Therapy for Solid Tumors on Recurrent/Metastatic Nasopharyngeal Carcinoma

SINGAPORE, July 16, 2024 /PRNewswire/ -- Biosyngen, a leading biotechnology company focused on the development of innovative cell therapies, recently announced that the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) inChina has approved the initiation of a...

2024-07-16 19:29 2122

Biosyngen's BRG01 enters Phase II clinical trial, a first-in-kind autologous EBV-Specific CAR-T Therapy for Solid Tumors on Recurrent/Metastatic Nasopharyngeal Carcinoma

SINGAPORE, July 16, 2024 /PRNewswire/ -- Biosyngen, a leading biotechnology company focused on the development of innovative cell therapies, recently announced that the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) inChina has approved the initiation of a...

2024-07-16 17:10 2328

WIPO Honours Vivo Surgical with Global Accolade for Innovation and IP Excellence

Pioneering Singaporean surgical robotics company selected from over 660 applicants worldwide to emerge as a winner of the coveted WIPO Global Awards for 2024 GENEVA, July 16, 2024 /PRNewswire/ -- Vivo Surgical, a privately-held medical technology company pioneering a flexible endoscopic robot fo...

2024-07-16 16:45 15196

In Honor of World Brain Day, the World Federation of Neurology to Host Free Public Webinar to Spotlight Brain Health and Disease Prevention

LONDON, July 15, 2024 /PRNewswire/ -- The World Federation of Neurology (WFN) is hosting its 11th annual World Brain Day on July 22. This year, World Brain Day will unite neurologists, patients, advocates and educators all over the world under the theme "Brain Health and Prevention."

2024-07-15 20:30 2659

CooperVision Champions Children's Eye Health at WCPOS V 2024

Global Myopia Management Leader Showcases Long-Term Benefits of MiSight® 1 day KUALA LUMPUR, Malaysia, July 15, 2024 /PRNewswire/ -- CooperVision , a global leader in myopia management, successfully concluded its impactful participation as a Gold sponsor at the5

2024-07-15 14:00 8116

CPHI & PMEC Shenzhen 2024: Fostering New Opportunities in Asia and China's Greater Bay Area

SHANGHAI, July 15, 2024 /PRNewswire/ -- CPHI & PMEC China 2024 concluded in June with an exceptional turnout of visitors, setting a new attendance record. Notably, the number of international visitors grew to 11,563, and professionals from the end-to-end pharmaceutical supply chain made meaningfu...

2024-07-15 13:59 1775

Everest Medicines Announces Positive Topline Results from Maintenance Period of Etrasimod Phase 3 Clinical Trial Conducted in Asia for the Treatment of Moderately-to-Severely Active Ulcerative Colitis

SHANGHAI, July 15, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced positive topline data results of the ...

2024-07-15 13:44 1853

Basecare Medical (2170. HK) revenue growth exceeds 50% in 2024H1

SUZHOU, China , July 15, 2024 /PRNewswire/ -- Basecare Medical (2170. HK) released an unaudited interim performance forecast onJuly 12th, stating that the company's revenue for the first half of the year was approximatelyRMB 127 million to RMB 138 million, an increase of approximately 49% to 62% ...

2024-07-15 12:17 3222

Physta® Tongkat Ali: Breakthrough Antiviral Study Reinforces Immune-Boosting & Healthy Ageing Benefits

KUALA LUMPUR, Malaysia, July 15, 2024 /PRNewswire/ -- In a significant breakthrough for the nutraceutical industry, Physta® Tongkat Ali, a proprietary extract of the traditional herbEurycoma longifolia from Biotropics Malaysia, has been spotlighted in a recently published study for its potent ant...

2024-07-15 08:00 7741

Shenzhen Hosts the 2nd AGP&DTx Summit Forum: Advancing Digital Therapeutics in Diabetes Management

SHENZHEN, China, July 12, 2024 /PRNewswire/ -- On July 5th, the 2nd Ambulatory Glucose Profile (AGP) & Digital Therapeutics (DTx), led by the National Innovation Center for Advanced Medical Devices, sponsored by China AGP and DTx Digital Therapeutics R&D Center ("R&D Center"), co-sponsored by She...

2024-07-12 17:09 3835

MGI Tech Launches DNBSEQ-G400RS FluoXpert in the APAC Region at Medlab Asia & Asia Health 2024

BANGKOK, July 12, 2024 /PRNewswire/ -- MGI Tech Co., Ltd. ("MGI"), a company committed to building core tools and technologies that drive innovation in life science, today launched DNBSEQ-G400RS FluoXpert in the APAC region and opened early access to the platform at Medlab Asia & Asia Health 2024...

2024-07-12 16:57 3402

Sirnaomics Announces Completion of IND-Enabling Studies of Safety and Efficacy for STP125G with NHP Models, Targeting ApoC3 for Treatment of Cardiovascular Diseases

HONG KONG, GERMANTOWN, Md. and SUZHOU, China, July 12, 2024 /PRNewswire/ -- Sirnaomics Ltd.(the "Company", Stock Code: 2257.HK, together with its subsidiaries, the "Group" or "Sirnaomics"), a leading biopharmaceutical company engaging in discovery and development of advanced RNAi therapeutics, an...

2024-07-12 16:53 4280

CUHK identifies novel gut microbiome biomarkers to facilitate diagnosis of autism spectrum disorders

Pilot clinical study shows modulation of gut microbiome alleviates anxiety symptoms  HONG KONG, July 11, 2024 /PRNewswire/ -- The Chinese University of Hong Kong (CUHK)'s Faculty of Medicine (CU Medicine) has conducted a large cohort study among 1,627 children with and without autism spectrum di...

2024-07-11 20:55 2566

Prenetics, NASDAQ Health Sciences Company, Partners with David Beckham

* Beckham becomes a strategic investor in Prenetics * Beckham and Prenetics are co-founding partners for IM8, a new health and wellness brand LOS ANGELES, July 11, 2024 /PRNewswire/ -- Prenetics, (NASDAQ: PRE) a leading health sciences company, is proud to announce that former international...

2024-07-11 20:48 2958

Newest Version of LifeSphere® Regulatory Platform Allows Organizations to Leverage Latest GenAI Technology

End-to-end functionality helps cut skyrocketing costs of compliance & removes workflow inefficiencies * The cloud-based platform demonstrates 50%+ efficiency gains across Regulatory Operations by bringing together data, content, and processes in a single ecosystem. * Platform is interoperabl...

2024-07-11 20:00 2115

CUHK identifies novel gut microbiome biomarkers to facilitate diagnosis of autism spectrum disorders

Pilot clinical study shows modulation of gut microbiome alleviates anxiety symptoms  HONG KONG, July 11, 2024 /PRNewswire/ -- A research team from The Chinese University of Hong Kong (CUHK)'s Faculty of Medicine (CU Medicine) has conducted a large cohort study among 1,627 children with and witho...

2024-07-11 18:36 7289

Initiation of cell therapy research and development program for adult T-Cell leukemia / lymphoma (ATLL)

Initiation of cell therapy research and development program for adult T-Cell leukemia / lymphoma (ATLL) TOKYO, July 11, 2024 /PRNewswire/ -- The National Cancer Center (Tokyo, Japan ) and TheUniversity of Pennsylvania (Philadelphia, PA, USA) have licensed patent rights directed to a chimeric...

2024-07-11 14:24 2448

Medit Appoints Han Ryu as CEO, Focusing on Customer-Centric Innovation

SEOUL, South Korea, July 11, 2024 /PRNewswire/ -- Medit, a global leader in dental 3D scanners and digital dentistry solutions, has appointedHan Ryu as its new CEO. Ryu brings with him over three decades of senior management experience in global medical device and healthcare companies, including ...

2024-07-11 09:00 2135

Telix Welcomes CMS Proposal to Improve Payment for Specialised Diagnostic Radiopharmaceuticals

MELBOURNE, Australia, July 11, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today welcomes proposed changes announced by the Centers for Medicare & Medicaid Services (CMS) for the Hospital Outpatient Prospective Payment System (OPPS) rule to improve payments ...

2024-07-11 08:21 1868

Eligo Publishes in Nature a Landmark Study That Unlocks Genome Editing of Bacteria in the Gut

PARIS, July 10, 2024 /PRNewswire/ -- For the first time, a team of scientists at Eligo has demonstrated it was possible to genetically modify bacteria with nearly 100% efficiency directly in the gut of animals. This work provides scientists with a novel strategy to better understand how genes fro...

2024-07-10 23:00 1729
1 ... 25262728293031 ... 396